- Home
- CTSO vs LODE Comparison
CTSO vs LODE Comparison
Compare CTSO & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- LODE
- Stock Information
- Founded
- CTSO 1997
- LODE 2008
- Country
- CTSO United States
- LODE United States
- Employees
- CTSO N/A
- LODE N/A
- Industry
- CTSO Medical/Dental Instruments
- LODE Major Chemicals
- Sector
- CTSO Health Care
- LODE Industrials
- Exchange
- CTSO Nasdaq
- LODE Nasdaq
- Market Cap
- CTSO 52.6M
- LODE 53.0M
- IPO Year
- CTSO N/A
- LODE N/A
- Fundamental
- Price
- CTSO $1.03
- LODE $3.73
- Analyst Decision
- CTSO Buy
- LODE Buy
- Analyst Count
- CTSO 2
- LODE 1
- Target Price
- CTSO $5.50
- LODE $26.00
- AVG Volume (30 Days)
- CTSO 134.9K
- LODE 535.6K
- Earning Date
- CTSO 08-12-2025
- LODE 08-07-2025
- Dividend Yield
- CTSO N/A
- LODE N/A
- EPS Growth
- CTSO N/A
- LODE N/A
- EPS
- CTSO N/A
- LODE N/A
- Revenue
- CTSO $35,332,238.00
- LODE $3,376,027.00
- Revenue This Year
- CTSO $18.34
- LODE $33.58
- Revenue Next Year
- CTSO $19.82
- LODE N/A
- P/E Ratio
- CTSO N/A
- LODE N/A
- Revenue Growth
- CTSO 15.37
- LODE 102.20
- 52 Week Low
- CTSO $0.71
- LODE $1.26
- 52 Week High
- CTSO $1.61
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- LODE 56.94
- Support Level
- CTSO $0.93
- LODE $3.54
- Resistance Level
- CTSO $1.39
- LODE $3.92
- Average True Range (ATR)
- CTSO 0.13
- LODE 0.28
- MACD
- CTSO -0.02
- LODE -0.04
- Stochastic Oscillator
- CTSO 34.92
- LODE 40.48
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.